Pfizer will list its COVID-19 treatment Paxlovid at a price of $1,390 per five-day course when it soon hits the commercial market, the drugmaker confirmed to Axios.

Why it matters: Paxlovid’s new listed price, first reported by the Wall Street Journal, will be more than twice the $529 paid by the federal government, which until now has maintained the entire U.S. supply of the key antiviral medication.

  • @[email protected]
    link
    fedilink
    -11 year ago

    You weren’t the person who said they didn’t pay in response to a comment about government paying so I have no idea what the point of your comment is other than “I am smart and I want to passively put you down.”

    • @nixcamic
      link
      21 year ago

      Everyone knows their taxes pay for the government dude.

      Also I didn’t pay for my COVID shot cause I got it in a country I don’t pay taxes in haha